Compounds > 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Pheochromocytoma, Extra-Adrenal

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Pheochromocytoma, Extra-Adrenal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Ballesta-Moratalla, M; Bello-Arques, P; Del Olmo-García, MI; Merino-Torres, JF; Olivas-Arroyo, C; Prado-Wohlwend, S; Torres-Espallardo, I1
Al-Jundi, M; Auh, S; Carrasquillo, JA; Del Rivero, J; Gubbi, S; Jha, A; Klubo-Gwiezdzinska, J; Knue, M; Lin, FI; Lindenberg, L; Mena, E; Meuter, L; Pacak, K; Shamis, I; Teng, Y; Turkbey, B; Zou, J1

Other Studies

2 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Pheochromocytoma, Extra-Adrenal

ArticleYear
Same-day comparative protocol PET/CT-PET/MRI [
    Cancer imaging : the official publication of the International Cancer Imaging Society, 2023, Jan-10, Volume: 23, Issue:1

    Topics: Adrenal Gland Neoplasms; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Precision Medicine

2023
Early short-term effects on catecholamine levels and pituitary function in patients with pheochromocytoma or paraganglioma treated with [
    Frontiers in endocrinology, 2023, Volume: 14

    Topics: Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Aged; Catecholamines; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Male; Middle Aged; Pheochromocytoma; Prolactin; Retrospective Studies; Thyrotropin

2023